stock price decline

Navan stock plunges 63% following securities fraud allegations over undisclosed $95M sales expense spike and CFO departure post-IPO.

GoDaddy stock fell 14% to $79.14 after disappointing Q4 results, weak 2026 guidance, and a securities fraud investigation announcement by the Portnoy Law Firm.

Class action suits filed against Ultragenyx and Mereo BioPharma following failed Phase III trials for setrusumab, with stock prices crashing 42.32% and 87.7% respectively.

Class actions filed against BlackRock TCP and Plug Power over alleged disclosure failures—BlackRock TCP faces NAV understatement claims following 19% decline; Plug Power accused of overstating DOE funding prospects.

Class action lawsuit filed against Ardent Health for allegedly inflating receivables. Stock plunged 34% after $43M revenue decrease revealed in Q3 2025.

Ultragenyx Pharmaceutical faces securities fraud lawsuit after setrusumab trials failed. Stock crashed 42% in December; investors have until April 6, 2026, to join action.

Rosen Law Firm investigates GSI Technology ($GSIT) for allegedly misleading claims about AI chip capabilities, following a 14.2% stock plunge on February 4, 2026.

Law firm launches class action against $NAVN over alleged failure to disclose surge in sales and marketing expenses following October 2025 offering.

Kyndryl faces securities fraud class action after CFO departure, SEC investigation, and filing delays spark 54.9% stock crash.

Class action lawsuit filed against $QURE over alleged misstatements about AMT-130 gene therapy FDA approval status. Stock plunged 49% after FDA reversed position on Phase I/II data adequacy.

Law firm investigates Trip.com for potential securities fraud after 18% stock plunge following China's antitrust notice.

Trip.com stock plummets 18% after China's antitrust regulator launches investigation; U.S. law firm files securities fraud claim citing inadequate disclosure.

Portnoy Law Firm investigates Baidu for potential securities fraud after Pentagon linked it to Chinese military. Stock fell 1.3% to $116.34 on November 26, 2025.

PennyMac Financial Services ($PFSI) stock crashed 33% after revealing servicing income fell 76% quarter-over-quarter, prompting securities investigation.

Law firm investigates $WMK after announcing restatement of fiscal 2022-2024 financials due to inventory overstatement, triggering 7.16% stock decline.

HUBG disclosed accounting errors understating transportation costs, prompting Q1-Q3 2025 restatement. Stock fell 18.3% on disclosure; law firm investigates shareholder claims.

Pomerantz LLP investigates KDDI Corporation following earnings postponement tied to internal probe. Stock fell 11.44% to $15.71.

Robbins LLP filed class action against $KD over alleged financial statement misstatements and internal control failures. Stock plunged 55% after SEC investigation disclosure.

Corcept Therapeutics faces class action lawsuit after FDA rejected relacorilant drug application, triggering 50% stock collapse and disclosure allegations.

NuScale Power faces class action lawsuit after paying $495M to inexperienced nuclear startup ENTRA1, triggering 12.4% stock plunge and investor claims of material risk concealment.